NanoSpot.ai, Opto to distribute SARS-CoV-2 antibody test in Greece

LabPulse.com staff writers
Sep 12, 2022
2022 04 22 17 54 4420 Business Handshake Man 400

NanoSpot.ai on Tuesday announced an agreement with Opto, a provider of connected diagnostic tests, for the distribution of NanoSpot.ai’s SARS-CoV-2 Total Antibody Test in Greece.

The partnership resulted from a joint clinical study in Athens that evaluated NanoSpot.ai's artificial intelligence (AI)-enabled, agglutination-based testing platform.

Its SARS-CoV-2 Total Antibody Test leverages the agglutination-based method and an AI-enabled mobile application to provide antibody test results at point-of-care.

The approach has demonstrated 98% sensitivity and 100% specificity, and provides results in less than three minutes, NanoSpot.ai said.

The firm received the CE Mark for the test in May.

Latest in Artificial Intelligence
Pharmaceutical Artificial Intelligence Social
Researchers design AI model to generate new antibiotics
April 9, 2024
Artificial Intelligence Ai Hand Social
Ibex presents new study data for AI-powered cancer diagnostics platform
March 26, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Ai Woman Social
AI foundation models set new benchmarks in computational pathology
March 20, 2024
Related Stories
2021 11 12 17 39 5991 Coronavirus Covid Blue 400
Molecular Diagnostics
Quest Diagnostics sees decline in August COVID test demand
2022 09 09 16 29 7140 Computer Head 400
Immune System Diseases
Lunaphore, Nucleai to provide AI-based spatial biology analysis
2018 08 28 18 59 9066 Artificial Intelligence Ai 400
Artificial Intelligence
Using the human voice to detect COVID, COPD
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Artificial Intelligence
Researchers design AI model to generate new antibiotics
By LabPulse.com staff writers
Researchers have devised an artificial intelligence (AI) model to develop potential new antibiotics which chemists can synthesize in the lab.
April 9, 2024
Pharmaceutical Artificial Intelligence Social
Ibex presents new study data for AI-powered cancer diagnostics platform
By Matt Limb
Ibex Medical Analytics is hailing positive data from studies with U.S. partners on the impact of its artificial intelligence (AI)-powered cancer diagnostic platform Galen.
March 26, 2024
Artificial Intelligence Ai Hand Social
Protein design firm Profluent raises $35M in funding
By LabPulse.com staff writers
Protein design firm Profluent has raised $35 million in funding, bringing the total funding raised by the company to $44 million.
March 25, 2024
Computer Brain Money Social
AI foundation models set new benchmarks in computational pathology
By Nick Paul Taylor
Mass General Brigham researchers have published a pair of papers on artificial intelligence (AI) systems that could improve tasks that include the analysis of pathology images and identification of rare diseases.
March 20, 2024
Ai Woman Social
Machine-learning model predicts lung and liver cancer through genome sequence changes
By LabPulse.com staff writers
Researchers have developed a machine-learning approach that may potentially predict early-stage lung or liver cancer by detecting repetitive sequences in the genome.
March 15, 2024
Artificial Intelligence Lung Color Social
Zephyr AI closes $111M series A funding round
By LabPulse.com staff writers
Biotech startup Zephyr AI announced on Wednesday that it successfully closed a $111 million series A funding round.
March 13, 2024
Artificial Intelligence Drug Design Funding Social
Predictive AI model might aid early-stage NSCLC planning
By Liz Carey
The deep-learning AI model identified features that were not readily discernable to a trained pathologist.
March 12, 2024
Cancer Lung 3 D Black Social
Study: AI assists discovery of prostate cancer subtypes
By Matt Limb
Prostate tumors have been found to evolve along multiple pathways, leading to two distinct disease types with “pivotal” implications for diagnosis and treatment, say scientists.
March 8, 2024
3 D Prostate Cancer Viral Social
Ibex, PathPresenter ink partnership
By LabPulse.com staff writers
Ibex Medical Analytics (Ibex) and PathPresenter announced a partnership to enable wider use of AI-enabled digital pathology for their joint customers.
March 6, 2024
Hands Shaking2 Social
EnsoData’s AI-powered sleep study diagnostic gets FDA 510(k) clearance
By LabPulse.com staff writers
EnsoData has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its machine learning-based diagnostic for sleep apnea and other sleep disorders that uses data from pulse oximetry devices.
February 26, 2024
Fda Button Social
Opentrons Labworks unveils AI-powered workflow tools
By Matt Limb
Lab automation and robotics firm Opentrons Labworks Inc has unveiled new tools intended to enhance the efficiency of research across genomics, proteomics, cell biology, and synthetic biology.
February 8, 2024
Artificial Intelligence Ai Hand Social
BD, Techcyte team for AI-enabled digital cervical cytology system
By LabPulse.com staff writers
Becton Dickinson (BD) and Techcyte have announced a strategic collaboration agreement designed to, in time, add artificial intelligence (AI) to cervical cancer screening in the U.S.
January 30, 2024
Business Handshake Intelligence Social
Page 1 of 17
Next Page